GLORIA PHARMA.
0024372.850.35% ( +0.01 )
GLORIA PHARMA. (002437)
HARBIN GLORIA PHARMACEUTICALS Co., LTD, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in...
- Open
- 2.84
- High
- 2.87
- Low
- 2.82
- Prev. Close
- 2.84
- Volume
- 452.67K
- Turnover
- 128.97M
- Avg Price
- 2.85
- Bid/Ask Ratio
- --
- Amplitude
- 1.76%
- 52wk High
- 4.08
- Volume Ratio
- 0.42
- Turnover Ratio
- 2.05%
GLORIA PHARMA. Analyst Rating
View MoreForecast & Rating
Oct 8, 2025Price forecast
¥3.2313.33%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 10:06 PM
Midday announcement: GLORIA PHARMA plans to sign an agreement to resolve the debt dispute related to the equity transfer of GLORIA BIO
- Zhitong · Nov 3, 2025 at 10:01 PM
GLORIA PHARMA: Puxing Puli plans to transfer 20.64% equity of GLORIA PHARMA to repay the debts owed by Puxing Puli to the company
- Zhitong · Oct 13, 2025 at 03:41 AM
GLORIA PHARMA: Provides guarantees for 40 million bank credit for two wholly-owned subsidiaries
- Zhitong · Aug 26, 2025 at 05:40 AM
GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-year
- Zhitong · Jun 24, 2025 at 04:34 AM
GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation
- Zhitong · Jun 3, 2025 at 03:39 AM
GLORIA PHARMA's subsidiary signed a marketing service agreement with Eisai China Pharmaceutical for Mecobalamin Injection
